Blog Posts

Cardiovascular Trials in the Digital Age: Wearables and Remote Monitoring

• January 22, 2024

Cardiovascular diseases (CVDs) stand as the foremost global cause of mortality, claiming an estimated 17.9 million lives in 2019 , constituting 32% of all deaths worldwide. Alarmingly, over three-quarters of CVD-related deaths occur in low- and middle-income countries.

Investigational Medicinal Product (IMP) Handling in Clinical Trials: Insights from Nepal

• January 22, 2024

National Guideline On Clinical Trials With The Use Of Pharmaceutical Products , published by National Health Research Council (NHRC) defines Investigational Medicinal Product (IMP/IP) as any pharmaceutical form of an active ingredient or placebo undergoing testing in a clinical trial.

Patient Advocacy in Clinical Trials

• January 22, 2024

The infamous Tuskegee Syphilis Study , spanning from 1932 to 1972 in Alabama, shockingly lacked essential patient safety measures, leading to its eventual termination. Victims of the study were not only left uninformed about syphilis, but they were also denied access to available treatment facilities.

Smart Science: AI Revolutionizing Clinical Trial Management

• January 22, 2024

‘The future is smart. The future is AI.’

As we stand on the brink of a transformative era, the future is undeniably intertwined with the capabilities and innovations that AI brings to the forefront. From healthcare to industry, education to entertainment, the influence of AI is pervasive.